The m6A modulator-mediated cytarabine sensitivity and immune cell infiltration signature in acute myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The m6A modulator-mediated cytarabine sensitivity and immune cell infiltration signature in acute myeloid leukemia

Published:2023-06-30 Issue:13 Volume:149 Page:11457-11469
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Yang Jincai,Li Liangliang,Cheng Juan,Lu Jianle,Zhang Shuling,Wang Shan,Zhao Li,Zhou Lanxia

Funder

In-Hospital Fund of the First Hospital of Lanzhou University

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-05029-x.pdf

Reference34 articles.

1. Briot T, Roger E, Thépot S, Lagarce F (2018) Advances in treatment formulations for acute myeloid leukemia. Drug Discov Today 23(12):1936–1949. https://doi.org/10.1016/j.drudis.2018.05.040

2. Cancro MP, Tomayko MM (2021) Memory B cells and plasma cells: the differentiative continuum of humoral immunity. Immunol Rev 303(1):72–82. https://doi.org/10.1111/imr.13016

3. Chen H, Xiang Y, Yin Y, Peng J, Peng D, Li D et al (2021) The m6A methyltransferase METTL3 regulates autophagy and sensitivity to cisplatin by targeting ATG5 in seminoma. Transl Androl Urol 10(4):1711–1722. https://doi.org/10.21037/tau-20-1411

4. Dou L, Xu Q, Wang M, Xiao Y, Cheng L, Li H et al (2019) Clinical efficacy of decitabine in combination with standard-dose cytarabine, aclarubicin hydrochloride, and granulocyte colony-stimulating factor in the treatment of young patients with newly diagnosed acute myeloid leukemia. Onco Targets Ther 12:5013–5023. https://doi.org/10.2147/ott.S200005

5. Estey EH (2018) Acute myeloid leukemia: 2019 update on risk-stratification and management. Am J Hematol 93(10):1267–1291. https://doi.org/10.1002/ajh.25214

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small molecule inhibitors targeting m6A regulators;Journal of Hematology & Oncology;2024-05-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3